Alterations in blood sugar, protein, and lipid levels in Indian women by norethisterone enanthate.
Fasting levels of sugar, protein, and lipids, namely, cholesterol, triglyceride, and phospholipid, were determined in the blood of 150 women taking an injectable contraceptive, norethisterone enanthate, 200 mg every 60 days for 24 months. Triglyceride and cholesterol showed a statistically significant decrease from 10 and 16 months of use; however, both values returned to control level after use for 24 months. Serum phospholipids and total protein did not show significant changes, while the blood sugar level increased significantly from 12 months onwards and remained elevated (P less than .001) up to the end of the trial period.
D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism*; D002784:Cholesterol / Q000097:blood; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D009640:Norethindrone / Q000009:adverse effects / Q000031:analogs & derivatives*; D010743:Phospholipids / Q000097:blood; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D001798:Blood Proteins; D003271:Contraceptive Agents, Female; D008055:Lipids; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol; C024319:norethindrone enanthate; D009640:Norethindrone